{"id":"W2144794315","doi":"10.3899/jrheum.140103","title":"Tuberculosis Risk in Patients Treated with Non-Anti-Tumor Necrosis Factor-  (TNF- ) Targeted Biologics and Recently Licensed TNF-  Inhibitors: Data from Clinical Trials and National Registries","year":2014,"lang":"en","type":"review","venue":"Journal of Rheumatology Supplement","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Certolizumab pegol; Golimumab; Tocilizumab; Internal medicine; Rheumatoid arthritis; Tuberculosis; Abatacept; Anakinra; Adalimumab; Rituximab; Tumor necrosis factor alpha; TNF inhibitor; Immunology; Lymphoma; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004387141,0.0002921963,0.002548237,0.002732736,0.0001403306,0.001025232,0.0004388562,0.000594351,0.0008477572],"category_scores_gemma":[0.01356175,0.0002814302,0.002650506,0.004602863,0.0003124829,0.0007053437,0.0003854033,0.0004188983,0.0001079472],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004389686,"about_ca_system_score_gemma":0.00120475,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000730634,"about_ca_topic_score_gemma":0.001645741,"domain_scores_codex":[0.9930868,0.001918412,0.00320876,0.0007877955,0.0008896599,0.0001086042],"domain_scores_gemma":[0.9751362,0.01559013,0.007540494,0.0004865533,0.001094247,0.000152465],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.004406871,0.0001224022,0.2646841,0.3095722,0.04749765,0.0007127477,0.0005186814,0.0006907954,0.001273604,0.0007093254,0.003923378,0.3658882],"study_design_scores_gemma":[0.001207823,0.002181228,0.6870899,0.09328291,0.1312854,0.008039879,0.0007717647,0.0006176889,0.001395024,0.0008733813,0.07311714,0.0001379632],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02291575,0.9755015,0.0002149219,0.0001832253,0.00004550281,0.00003578488,0.0007542272,0.000004766483,0.0003442186],"genre_scores_gemma":[0.2018845,0.794917,0.0007726735,0.0005590526,0.0002227956,0.000176037,0.00136623,0.0000072381,0.00009440096],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004387141,"threshold_uncertainty_score":0.0232017,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1428815873117654,"score_gpt":0.4385177081894654,"score_spread":0.2956361208777001,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}